Kenneth Frazier
Kenneth Frazier
Kenneth Carleton FrazierDecember 17, 1954) is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co.. After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African-American to lead a major pharmaceutical company...
cases defend
We have substantial defenses in these cases and will defend them vigorously.
coming defend jury satisfied trials
Merck is satisfied with the jury verdict. There will be other VIOXX trials and we will vigorously defend them one by one over the coming years.
coming defend jury satisfied trials
Merck is satisfied with the jury verdict, ... There will be other VIOXX trials and we will vigorously defend them one by one over the coming years.
cases changed committing defending
We have not changed our strategy. We're committing to defending these cases one at a time.
addressing cases coming committed defend manner prepared remain trials
We are prepared to defend this and other cases in the future. There are many more trials to come. We remain committed to addressing these cases one by one in a responsible manner in the coming years.
cases defend intend litigation recognize
We recognize that this litigation is not over, that there are many more cases to go. We intend to defend these cases one by one.
case commitment defending split verdict
This split verdict reaffirms our commitment to defending each case on a case-by-case basis.
cases defending focus remains
The focus remains on defending these cases one at a time. We're in this for the long haul.
hope learn time
We have to do it better than we did in Angleton. Each time we do this, we learn and hope to sharpen our approaches.
acted evidence found jury
We feel very much vindicated. The jury found in our favor, we believe, because the evidence showed that Merck acted responsibly.
acted evidence found jury
We feel very much vindicated, ... The jury found in our favor, we believe, because the evidence showed that Merck acted responsibly.
address both cases resolve resources
We have both the resources and the resolve to address these cases over many years.
actions based believe case critical decisions flawed information presented result science sound texas
We believe that the Texas case was the result of fundamentally flawed information being presented to the jury. Merck's actions and decisions were based on sound science and in the long run, that's what is critical to patients.
allow anybody blank groups harm hurt intend open organized
We never intend to harm anybody or hurt anybody. But at the same time, we do not intend to allow people, or organized groups of lawyers, to use Merck as an open blank check.